Determining Functional Properties and Sources of Recently Identified Bioactive Food Components: Oligosaccharides, Glycolipids, Glycoproteins, and Peptides

Encyclopedia of Agriculture and Food Systems

Volumn , Issue , 2014, Pages 441-461

  Lange, M ^a   Lee, H ^b   Dallas, D ^b   Le Parc, A ^b   de Moura Bell, J M L N ^b   Barile, D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial; Bioactive compounds; Glycolipids; Glycoproteins; Industrial streams; Mass spectrometry; Oligosaccharides; Peptides; Prebiotics; Whey

Indexed keywords

EID: 84994813774     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-52512-3.00067-X     Document Type: Chapter

References (214)

1. Abdallah Ismail N., Ragab S.H., Abd ElBaky A., et al. Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Archives of Medical Science 2011, 7:501-507.
2. Abt M., Artis D. The intestinal microbiota in health and disease: The influence of microbial products on immune cell homeostasis. Current Opinion in Gastroenterology 2009, 25:496-502.
3. Aebi M., Bernasconi R., Clerc S., Molinari M. N-glycan structures: Recognition and processing in the ER. Trends in Biochemical Sciences 2010, 35:74-82.
4. Agyei D., Danquah M.K. Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnology Advances 2011, 29:272-277.
5. Albenberg L.G., Lewis J.D., Wu G.D. Food and the gut microbiota in inflammatory bowel diseases: A critical connection. Current Opinion in Gastroenterology 2012, 28:314-320.
6. Aldredge D.L., Geronimo M.R., Hua S., et al. Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures. Glycobiology 2013, 23:664-676.
7. Andersson B., Porras O., Hanson L.Å., Lagergård T., Svanborg-Edén C. Inhibition of attachment of Streptococcus pneumoniae and Haemophilus influenzae by human milk and receptor oligosaccharides. Journal of Infectious Diseases 1986, 153:232-237.
8. Aniansson G., Andersson B., Lindstedt R., Svanborg C. Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae. Microbial Pathogenesis 1990, 8:315-323.
9. Armougom F., Henry M., Vialettes B., Raccah D., Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One 2009, 4:e7125.
10. Arunkumar A., Etzel M.R. Fractionation of α-lactalbumin from β-lactoglobulin using positively charged tangential flow ultrafiltration membranes. Separation and Purification Technology 2013, 105:121-128.
11. Azuma N., Yamauchi K., Mitsuoka T. Bifidus growth-promoting activity of a glycomacropeptide derived from human k-casein. Agricultural and Biological Chemistry 1984, 48:2159-2162.
12. Baldasso C., Barros T.C., Tessaro I.C. Concentration and purification of whey proteins by ultrafiltration. Desalination 2011, 278:381-386.
13. Barboza M., Pinzon J., Wickramasinghe S., et al. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Molecular & Cellular Proteomics 2012, 11(6). M111.015248.
14. Barile D., Marotta M., Chu C., et al. Neutral and acidic oligosaccharides in Holstein-Friesian colostrum during the first 3 days of lactation measured by high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. Journal of Dairy Science 2010, 93:3940-3949.
15. Barile D., Tao N., Lebrilla C.B., et al. Permeate from cheese whey ultrafiltration is a source of milk oligosaccharides. International Dairy Journal 2009, 19:524-530.
16. Bellamy W., Takase M., Wakabayashi H., Kawase K., Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. Journal of Applied Bacteriology 1992, 73:472-479.
17. Bezkorovainy A., Grohlich D., Nichols J.H. Isolation of a glycopolypeptide fraction with Lactobacillus bifidus subspecies pennsylvanicus growth-promoting activity from whole human milk casein. American Journal of Clinical Nutrition 1979, 32:1428-1432.
18. Bhushan S., Etzel M.r. Charged ultrafiltration membranes increase the selectivity of whey protein separations. Journal of Food Science 2009, 74:E131-E139.
19. Björkstén B., Sepp E., Julge K., Voor T., Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. Journal of Allergy and Clinical Immunology 2001, 108:516-520.
20. Boehm G., Stahl B. Oligosaccharides from milk. Journal of Nutrition 2007, 137:847S-849S.
21. Bode L., Beermann C., Mank M., Kohn G., Boehm G. Human and bovine milk gangliosides differ in their fatty acid composition. Journal of Nutrition 2004, 134:3016-3020.
22. Bouchara J.P., Sanchez M., Chevailler A., et al. Sialic acid-dependent recognition of laminin and fibrinogen by Aspergillus fumigatus conidia. Infection and Immunity 1997, 65:2717-2724.
23. Brantl V. Novel opioid peptides derived from human casein: Human casomorphins. European Journal of Pharmacology 1984, 106:213-214.
24. Brønnum H., Seested T., Hellgren L.I., Brix S., Frøkiær H. Milk-derived GM3 and GD3 differentially inhibit dendritic cell maturation and effector functionalities. Scandinavian Journal of Immunology 2005, 61:551-557.
25. Challa A., Rao D.R., Chawan C.B., Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 1997, 18:517-521.
26. Charlwood J., Hanrahan S., Tyldesley R., et al. Use of proteomic methodology for the characterization of human milk fat globular membrane proteins. Analytical Biochemistry 2002, 301:314-324.
27. Chaturvedi P., Warren C.D., Altaye M., et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001, 11:365-372.
28. Cheryan M. Ultrafiltration and Microfiltration Handbook 1998, CRC Press, New York.
29. Chichlowski M., De Lartigue G., German J., Raybould H., Mills D. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. Journal of Pediatric Gastroenterology 2012, 55:321-327.
30. Clydesdale, F., 2005. Functional foods: Opportunities and challenges. IFT Expert Report. Washington, DC: Institute for Food Technologists.
31. Coppa G.V., Zampini L., Galeazzi T., et al. Human milk oligosaccharides inhibit the adhesion to caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatric Research 2006, 59:377-382.
32. Crane J.K., Azar S.S., Stam A., Newburg D.S. Oligosaccharides from human milk block binding and activity of the Escherichia coli heat-stable enterotoxin (STa) in T84 intestinal cells. Journal of Nutrition 1994, 124:2358-2364.
33. Cuartas-Uribe B., Alcaina-Miranda M.I., Soriano-Costa E., et al. A study of the separation of lactose from whey ultrafiltration permeate using nanofiltration. Desalination 2009, 241:244-255.
34. Culligan E.P., Hill C., Sleator R.D. Probiotics and gastrointestinal disease: Successes, problems and future prospects. Gut Pathogens 2009, 1:19.
35. Dallas D.C., Guerrero A., Khaldi N., et al. Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides. Journal of Proteome Research 2013, 12:2295-2304.
36. Dallas D.C., Underwood M.A., Zivkovic A.M., German J.B. Digestion of protein in premature and terms infant. Journal of Nutritional Disorders & Therapy 2012, 2:112-120.
37. Dallas, D.C., Weinborn, V., de Moura Bell, J.M.L., et al., 2013b. Comprehensive peptidomic and glycomic evaluation reveals sweet whey permeate from colostrum is a source of milk protein-derived peptides and oligosaccharides. Food Research International special issue "FoodOmics 2013".
38. De Moura J., Campbell K., Almeida N.M., de Glatz C.E., Johnson L.A. Protein extraction and membrane recovery in enzyme-assisted aqueous extraction processing of soybeans. Journal of the American Oil Chemists' Society 2011, 88:877-889.
39. De Moura J., Campbell K., Almeida N.M., de Glatz C.E., Johnson L.A. Protein recovery in aqueous extraction processing of soybeans using isoelectric precipitation and nanofiltration. Journal of the American Oil Chemists' Society 2011, 88:1447-1454.
40. De Moura J., Maurer D., Jung S., Johnson L.A. Pilot-plant proof-of-concept for integrated, countercurrent, two-stage, enzyme-assisted aqueous extraction of soybeans. Journal of the American Oil Chemists' Society 2011, 88:1649-1658.
41. Dennis E.A., Brown H.A., Deems R.A., et al. The LIPID MAPS approach to lipidomics. Functional Lipidomics 2005, 1-15. CRC Press/Taylor & Francis Group, London. L. Feng, G. Prestwich (Eds.).
42. Di Stefano V., Avellone G., Bongiorno D., et al. Applications of HPLC-MS for food analysis. Journal of Chromatography A 2012, 1259:74-85.
43. Donovan S.M., Wang M., Li M., et al. Host-microbe interactions in the neonatal intestine: Role of human milk oligosaccharides. Advance Nutrients 2012, 3:450S-455S.
44. Eiwegger T., Stahl B., Schmitt J., et al. Human milk-derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatric Research 2004, 56:536-540.
45. Elwell M.W., Barbano D.M. Use of microfiltration to improve fluid milk quality. Journal of Dairy Science 2006, 89(Suppl.):E20-E30.
46. Fahy E., Sud M., Cotter D., Subramaniam S. LIPID MAPS online tools for lipid research. Nucleic Acids Research 2007, 35:W606-W612.
47. Fantini J., Maresca M., Hammache D., Yahi N., Delézay O. Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconjugate Journal 2000, 17:173-179.
48. Farnaud S., Evans R.W. Lactoferrin - A multifunctional protein with antimicrobial properties. Molecular Immunology 2003, 40:395-405.
49. Finke B., Stahl B., Pfenninger A., et al. Analysis of high-molecular-weight oligosaccharides from human milk by liquid chromatography and MALDI-MS. Analytical Chemistry 1999, 71:3755-3762.
50. Fukuda S., Toh H., Hase K., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
51. German J.B., Dillard C.J., Ward R.E. Bioactive components in milk. Current Opinion in Clinical Nutrition & Metabolic Care 2002, 5:653-658.
52. Gopal P.K., Gill H.S. Oligosaccharides and glycoconjugates in bovine milk and colostrum. British Journal of Nutrition 2000, 84(Suppl. 1):S69-S74.
53. Goulas A.K., Grandison A.S., Rastall R.A. Fractionation of oligosaccharides by nanofiltration. Journal of the Science of Food and Agriculture 2003, 83:675-680.
54. Goulas A.K., Kapasakalidis P.G., Sinclair H.R., Rastall R.A., Grandison A.S. Purification of oligosaccharides by nanofiltration. Journal of Membrane Science 2002, 209:321-335.
55. Gry J., Black L., Eriksen F.D., et al. EuroFIR-BASIS - A combined composition and biological activity database for bioactive compounds in plant-based foods. Trends in Food Science & Technology 2007, 18:434-444.
56. Hakkarainen J., Toivanen M., Leinonen A., et al. Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro. Journal of Nutrition 2005, 135:2445-2448.
57. Hansen R., Dickson A.J., Goodacre R., Stephens G.M., Sellick C.A. Rapid characterization of N-linked glycans from secreted and gel-purified monoclonal antibodies using MALDI-ToF mass spectrometry. Biotechnology and Bioengineering 2010, 107:902-908.
58. Harvey D.J. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update covering the period 1999-2000. Mass Spectrometry Reviews 2006, 25:595-662.
59. He H., Conrad C.A., Nilsson C.L., et al. Method for lipidomic analysis: p53 Expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells. Analytical Chemistry 2007, 79:8423-8430.
60. Hernández-Ledesma B., del Mar Contreras M., Recio I. Antihypertensive peptides: Production, bioavailability and incorporation into foods. Advances in Colloid and Interface Science 2011, 165:23-35.
61. Holden J.M., Bhagwat S.A., Haytowitz D.B., et al. Development of a database of critically evaluated flavonoids data: Application of USDA's data quality evaluation system. Journal of Food Composition and Analysis 2005, 18:829-844.
62. Hong P., Ninonuevo M.R., Lee B., Lebrilla C., Bode L. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN). British Journal of Nutrition 2009, 101:482-486.
63. Hornef M.W., Wick M.J., Rhen M., Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nature Immunology 2002, 3:1033-1040.
64. Hua S., Jeong H.N., Dimapasoc L.M., et al. Isomer-specific LC/MS and LC/MS/MS profiling of the mouse serum N-glycome revealing a number of novel sialylated N-glycans. Analytical Chemistry 2013, 85:4636-4643.
65. Hua S., Nwosu C.C., Strum J.S., et al. Site-specific protein glycosylation analysis with glycan isomer differentiation. Analytical and Bioanalytical Chemistry 2012, 403:1291-1302.
66. Idota T., Kawakami H. Inhibitory effects of milk gangliosides on the adhesion of Escherichia coli to human intestinal carcinoma cells. Bioscience, Biotechnology, and Biochemistry 1995, 59:69-72.
67. Jenkins D.J.A., Kendall C.W.C., Vuksan V. Inulin, oligofructose and intestinal function. Journal of Nutrition 1999, 129:1431.
68. John R.P. Biotechnological potentials of cassava bagasse. Biotechnology for Agro-Industrial Residues Utilisation 2009, 225-237. Springer, The Netherlands. P.S. nee Nigam, A. Pandey (Eds.).
69. Jørgensen A.L.W., Juul-Madsen H.R., Stagsted J. Colostrum and bioactive, colostral peptides differentially modulate the innate immune response of intestinal epithelial cells. Journal of Peptide Science 2010, 16:21-30.
70. Jumpertz R., Le D.S., Turnbaugh P.J., et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. American Journal of Clinical Nutrition 2011, 94:58-65.
71. Jung S., de Moura J., Campbell K., Johnson L. Enzyme-assisted aqueous extraction of oilseeds. Enhancing Extraction Processes in the Food Industry 2012, 457-518. CRC Press, Boca Raton, FL. N. Lebovka (Ed.).
72. Kalliomäki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition 2008, 87:534-538.
73. Kalliomaki M., Isolauri E. Role of intestinal flora in the development of allergy. Current Opinion in Allergy & Clinical Immunology 2003, 3:15-20.
74. Kalliomäki M., Kirjavainen P., Eerola E., et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. Journal of Allergy and Clinical Immunology 2001, 107:129-134.
75. Kampa M., Loukas S., Hatzoglou A., et al. Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide). Biochemical Journal 1996, 319:903-908.
76. King J.C., Cummings G.E., Guo N., et al. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. Journal of Pediatric Gastroenterology and Nutrition 2007, 44:245-251.
77. Kinsella J.E. Functional properties of soy proteins. Journal of the American Oil Chemists' Society 1979, 56:242-258.
78. Kletter D., Singh S., Bern M., Haab B.B. Global comparisons of lectin-glycan interactions using a database of analyzed glycan array data. Molecular & Cellular Proteomics 2013, 12:1026-1035.
79. Korhonen H., Pihlanto A. Food-derived bioactive peptides - Opportunities for designing future foods. Current Pharmaceutical Design 2003, 9:1297-1308.
80. Korhonen H., Pihlanto A. Bioactive peptides: Production and functionality. International Dairy Journal 2006, 16:945-960.
81. Korhonen H., Pihlanto-Leppäla A., Rantamäki P., Tupasela T. Impact of processing on bioactive proteins and peptides. Trends in Food Science & Technology 1998, 9:307-319.
82. Kronewitter S.R., An H.J., de Leoz M.L., et al. The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics 2009, 9:2986-2994.
83. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annual Review of Nutrition 2000, 20:699-722.
84. Law B.A., Reiter B. The isolation and bacteriostatic properties of lactoferrin from bovine milk whey. Journal of Dairy Research 1977, 44:595-599.
85. Lawrence R.M., Pane C.A. Human breast milk: Current concepts of immunology and infectious diseases. Current Problems in Pediatric and Adolescent Health Care 2007, 37:7-36.
86. Ledeen R.W., Yu R.K. Gangliosides: Structure, isolation, and analysis. Methods in Enzymology 1982, 83:139-191.
87. Lee H., An H.J., Lerno L.A., German J.B., Lebrilla C.B. Rapid profiling of bovine and human milk gangliosides by matrix-assisted laser desorption/ionization fourier transform ion cyclotron resonance mass spectrometry. International Journal of Mass Spectrometry 2011, 305:138-150.
88. Lee H., German J.B., Kjelden R., Lebrilla C.B., Barile D. Quantitative analysis of gangliosides in bovine milk and colostrum-based dairy products by ultra-high performance liquid chromatography-tandem mass spectrometry. Journal of Agricultural and Food Chemistry 2013, 61:9689-9696.
89. Lee H., Lerno L.A., Choe Y., et al. Multiple precursor ion scanning of gangliosides and sulfatides with a reversed-phase microfluidic chip and quadrupole time-of-flight mass spectrometry. Analytical Chemistry 2012, 84:5905-5912.
90. Legrand D., Elass E., Carpentier M., Mazurier J. Lactoferrin: A modulator of immune and inflammatory responses. Cellular and Molecular Life Sciences 2005, 62:2549-2559.
91. Leoz M.L.A.D., Wu S., Strum J.S., et al. A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants. Analytical and Bioanalytical Chemistry 2013, 405:4089-4105.
92. Liepke C., Adermann K., Raida M., et al. Human milk provides peptides highly stimulating the growth of bifidobacteria. European Journal of Biochemistry 2002, 269:712-718.
93. Liepke C., Zucht H.-D., Forssmann W.-G., Ständker L. Purification of novel peptide antibiotics from human milk. Journal of Chromatography B: Biomedical Sciences and Applications 2001, 752:369-377.
94. Liu B., Yu Z., Chen C., Kling D.E., Newburg D.S. Human milk mucin 1 and mucin 4 inhibit Salmonella enterica serovar typhimurium invasion of human intestinal epithelial cells in vitro. Journal of Nutrition 2012, 142:1504-1509.
95. LoCascio R.G., Desai P., Sela D.A., Weimer B., Mills D.A. Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Applied and Environmental Microbiology 2010, 76:7373-7381.
96. Lonnerdal B., Iyer S. Lactoferrin: Molecular structure and biological function. Annual Review of Nutrition 1995, 15:93-110.
97. Manning T.S., Gibson G.R. Prebiotics. Best Practice & Research Clinical Gastroenterology 2004, 18:287-298.
98. Marcelo P.A., Rizvi S.S.H. Physicochemical properties of liquid virgin whey protein isolate. International Dairy Journal 2008, 18:236-246.
99. Marcobal A., Barboza M., Froehlich J.W., et al. Consumption of human milk oligosaccharides by gut-related microbes. Journal of Agricultural and Food Chemistry 2010, 58:5334-5340.
100. Marcobal A., Barboza M., Sonnenburg E.D., et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host & Microbe 2011, 10:507-514.
101. Marth J.D., Grewal P.K. Mammalian glycosylation in immunity. Nature Reviews Immunology 2008, 8:874-887.
102. Martinez-Ferez A., Rudloff S., Guadix A., et al. Goats' milk as a natural source of lactose-derived oligosaccharides: Isolation by membrane technology. International Dairy Journal 2006, 16:173-181.
103. Martino D.J., Currie H., Taylor A., Conway P., Prescott S.L. Relationship between early intestinal colonization, mucosal immunoglobulin A production and systemic immune development. Clinical & Experimental Allergy 2008, 38:69-78.
104. Marwaha S.S., Kennedy J.F. Whey - Pollution problem and potential utilization. International Journal of Food Science & Technology 1988, 23:323-336.
105. Maubois J.-L. Liquid milk products: Membrane-processed liquid milk. Encyclopedia of Dairy Sciences 2011, 307-309. Academic Press, San Diego. second ed. W.F. John (Ed.).
106. Merrill A.H., Sullards M.C., Allegood J.C., Kelly S., Wang E. Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods 2005, 36:207-224.
107. Migliore-Samour D., Floc'h F., Jollès P. Biologically active casein peptides implicated in immunomodulation. Journal of Dairy Research 1989, 56:357-362.
108. Miklavcic J.J., Schnabl K.L., Mazurak V.C., Thomson A.B., Clandinin M.T. Dietary ganglioside reduces proinflammatory signaling in the intestine. Journal of Nutrition and Metabolism 2012, 2012:1-8.
109. Minkiewicz P., Slangen C.J., Lagerwerf F.M., et al. Reversed-phase high-performance liquid chromatographic separation of bovine casein macropeptide and characterization of isolated fractions. Journal of Chromatography A 1996, 743:123-135.
110. Mistry N., Drobni P., Naslund J., et al. The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Research 2007, 75:258-265.
111. Møller A., Unwin I.D., Becker W., Ireland J. EuroFIR's food databank systems for nutrients and bioactives. Trends in Food Science & Technology 2007, 18:428-433.
112. Morr C.V., Ha E.Y.W. Whey protein concentrates and isolates: Processing and functional properties. Critical Reviews in Food Science and Nutrition 1993, 33:431-476.
113. Morrow A.L., Ruiz-Palacios G.M., Altaye M., et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. Journal of Pediatrics 2004, 145:297-303.
114. Morrow A.L., Ruiz-Palacios G.M., Jiang X., Newburg D.S. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. Journal of Nutrition 2005, 135:1304-1307.
115. Murdock C.a., Matthews K.r. Antibacterial activity of pepsin-digested lactoferrin on foodborne pathogens in buffered broth systems and ultra-high temperature milk with EDTA. Journal of Applied Microbiology 2002, 93:850-856.
116. Newburg D.S. Bioactive components of human milk: Evolution, protection and efficiency. Bioactive Components of Human Milk 2001, 3-10. Springer, New York, NJ. D.S. Newburg (Ed.).
117. Newburg D.S. Innate immunity and human milk. Journal of Nutrition 2005, 135:1308-1312.
118. Newburg D.S. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. Journal of Animal Science 2009, 87:26-34.
119. Newburg D.S., Chaturvedi P. Neutral glycolipids of human and bovine milk. Lipids 1992, 27:923-927.
120. Newburg D.S., Ruiz-Palacios G.M., Altaye M., et al. Human milk alphal,2-linked fucosylated oligosaccharides decrease risk of diarrhea due to stable toxin of E. coli in breastfed infants. Advances in Experimental Medicine and Biology 2004, 554:457-461.
121. Newburg D.S., Ruiz-Palacios G.M., Morrow A.L. Human milk glycans protect infants against enteric pathogens. Annual Review of Nutrition 2005, 25:37-58.
122. Niñonuevo M., An H., Yin H., et al. Nanoliquid chromatography-mass spectrometry of oligosaccharides employing graphitized carbon chromatography on microchip with a high-accuracy mass analyzer. Electrophoresis 2005, 26:3641-3649.
123. Ninonuevo M.R., Bode L. Infant formula oligosaccharides opening the gates (for speculation): Commentary on the article by Barrat et al. on page 34. Pediatric Research 2008, 64:8-10.
124. Niñonuevo M.R., Lebrilla C.B. Mass spectrometric methods for analysis of oligosaccharides in human milk. Nutrition Reviews 2009, 67:S216-S226.
125. Ninonuevo M.R., Park Y., Yin H., et al. A strategy for annotating the human milk glycome. Journal of Agricultural and Food Chemistry 2006, 54:7471-7480.
126. Niñonuevo M.R., Perkins P.D., Francis J., et al. Daily variations in oligosaccharides of human milk determined by microfluidic chips and mass spectrometry. Journal of Agricultural and Food Chemistry 2007, 56:618-626.
127. Nwosu C.C., Aldredge D.L., Lee H., et al. Comparison of the human and bovine milk N-glycome via high-performance microfluidic chip liquid chromatography and tandem mass spectrometry. Journal of Proteome Research 2012, 11:2912-2924.
128. Nwosu C.C., Seipert R.R., Strum J.S., et al. Simultaneous and extensive site-specific N- and O-glycosylation analysis in protein mixtures. Journal of Proteome Research 2011, 10:2612-2624.
129. Obermeier S., Rudloff S., Pohlentz G., Lentze M.J., Kunz C. Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral 13C-galactose load. Isotopes in Environmental and Health Studies 1999, 35:119-125.
130. Ochoa T.J., Chea-Woo E., Campos M., et al. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clinical Infectious Disease 2008, 46:1881-1883.
131. Ohtsubo K., Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 2006, 126:855-867.
132. Orsi N. The antimicrobial activity of lactoferrin: Current status and perspectives. Biometals 2004, 17:189-196.
133. Otnaess A.B., Laegreid A., Ertresvag K. Inhibition of enterotoxin from Escherichia coli and Vibrio cholerae by gangliosides from human milk. Infection and Immunity 1983, 40:563-569.
134. Pabst H.F., Spady D.W., Pilarski L.M., et al. Differential modulation of the immune response by breast- or formula-feeding of infants. Acta Paediatrica 1997, 86:1291-1297.
135. Packer N.H., Lawson M.A., Jardine D.R., Redmond J.W. A general approach to desalting oligosaccharides released from glycoproteins. Glycoconjugate Journal 1998, 15:737-747.
136. Park E.J., Suh M., Thomson B., et al. Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide. Shock 2007, 28:112-117.
137. Pfenninger A., Karas M., Finke B., Stahl B. Structural analysis of underivatized neutral human milk oligosaccharides in the negative ion mode by nano-electrospray MS(n) (part 1: methodology). Journal of the American Society for Mass Spectrometry 2002, 13:1331-1340.
138. Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F. Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry. Proteomics 2008, 8:3833-3847.
139. Pouliot Y. Membrane processes in dairy technology - From a simple idea to worldwide panacea. International Dairy Journal 2008, 18:735-740.
140. Proctor L.M. The human microbiome project in 2011 and beyond. Cell Host & Microbe 2011, 10:287-291.
141. Qin J., Li R., Raes J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
142. Ramchandran L., Vasiljevic T. Whey processing. Membrane Processing 2013, 193-207. Blackwell Publishing Ltd., Oxford, UK. A.Y. Tamime (Ed.).
143. Rastall R.A., Maitin V. Prebiotics and synbiotics: Towards the next generation. Current Opinion in Biotechnology 2002, 13:490-496.
144. Reddy B.S., Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo [4, 5-f] quinoline, a food mutagen. Cancer Research 1993, 53:3914-3918.
145. Reinhardt C., Reigstad C., Backhed F. Intestinal microbiota during infancy and its implications for obesity. Journal of Pediatric Gastroenterology 2009, 48:249-256.
146. Rendi D., Wilson I.B.H., Lubec G., et al. Adaptation of the "in-gel release method" to N-glycome analysis of low-milligram amounts of material. Electrophoresis 2007, 28:4484-4492.
147. Rosenberg M. Current and future applications for membrane processes in the dairy industry. Trends in Food Science & Technology 1995, 6:12-19.
148. Rothwell, J.A., Urpi-Sarda, M., Boto-Ordonez, M., et al., 2012. Phenol-Explorer 2.0: A major update of the Phenol-Explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database (Oxford). doi: 10.1093/database/bas031.
149. Rowland I.R., Rumney C.J., Coutts J.T., Lievense L.C. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 1998, 19:281-285.
150. Rudloff S., Pohlentz G., Diekmann L., Egge H., Kunz C. Urinary excretion of lactose and oligosaccharides in preterm infants fed human milk or infant formula. Acta Paediatrica 1996, 85:598-603.
151. Rueda R. The role of dietary gangliosides on immunity and the prevention of infection. British Journal of Nutrition 2007, 98(Suppl. 1):S68-S73.
152. Rueda R., Sabatel J.L., Maldonado J., Molina-Font J.A., Gil A. Addition of gangliosides to an adapted milk formula modifies levels of fecal Escherichia coli in preterm newborn infants. Journal of Pediatrics 1998, 133:90-94.
153. Saito T., Yamaji A., Itoh T. A new isolation method of caseinoglycopeptide from sweet cheese whey. Journal of Dairy Science 1991, 74:2831-2837.
154. Sakata S., Tonooka T., Ishizeki S., et al. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiology Letters 2005, 243:417-423.
155. Sanchez L., Calvo M., Brock J.H. Biological role of lactoferrin. Archives of Disease in Childhood 1992, 67:657-661.
156. Sanders M.E. Considerations for use of probiotic bacteria to modulate human health. Journal of Nutrition 2000, 130:384S-390S.
157. Sarney D.B., Hale C., Frankel G., Vulfson E.N. A novel approach to the recovery of biologically active oligosaccharides from milk using a combination of enzymatic treatment and nanofiltration. Biotechnology and Bioengineering 2000, 69:461-467.
158. Schanbacher F.L., Talhouk R.S., Murray F.A. Biology and origin of bioactive peptides in milk. Livestock Production Science 1997, 50:105-123.
159. Schingoethe D.J. Whey utilization in animal feeding: A summary and evaluation. Journal of Dairy Science 1976, 59:556-570.
160. Scoma A., Pintucci C., Bertin L., Carlozzi P., Fava F. Increasing the large scale feasibility of a solid phase extraction procedure for the recovery of natural antioxidants from olive mill wastewaters. Chemical Engineering Journal 2012, 198-199:103-109.
161. Scott, S.N., Krishnapillai, A., 2012. Isolation and Purification of Components of Whey. US Patent Application Publication, 17 May 2012, US 2012/0121788 A1.
162. Seganti L., Biase A.M.D., Marchetti M., et al. Antiviral activity of lactoferrin towards naked viruses. Biometals 2004, 17:295-299.
163. Seifert S., Watzl B. Inulin and oligofructose: Review of experimental data on immune modulation. Journal of Nutrition 2007, 137:2563S-2567S.
164. Sela D.A., Garrido D., Lerno L., et al. Bifidobacterium longum subsp. infantis ATCC 15697 fucosidases are active on fucosylated human milk oligosaccharides. Applied and Environmental Microbiology 2012, 78:795-803.
165. Sela D.A., Li Y., Lerno L., et al. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. Journal of Biological Chemistry 2011, 286:11909-11918.
166. Sela D.A., Mills D.A. Nursing our microbiota: Molecular linkages between bifidobacteria and milk oligosaccharides. Trends in Microbiology 2010, 18:298-307.
167. Senkovich O., Cook W.J., Mirza S., et al. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism. Journal of Molecular Biology 2007, 370:701-713.
168. Sepp E., Julge K., Vasar M., et al. Intestinal microflora of Estonian and Swedish infants. Acta Paediatrica 1997, 86:956-961.
169. Serban D.E. The gut microbiota in the metagenomics era: Sometimes a friend, sometimes a foe. Roumanian archives of Microbiology and Immunology 2011, 70:134-140.
170. Shabana I.I., ALgammal A.M., Suzuki H. Molecular typing of the enteroaggregative E. coli heat-stable enterotoxin 1 gene (EAST1) in E. coli strains isolated from human and calves with diarrhea. Global Animal Science Journal 2013, 1(1):1128-1138.
171. Shental-Bechor D., Levy Y. Folding of glycoproteins: Toward understanding the biophysics of the glycosylation code. Current Opinion in Structural Biology 2009, 19:524-533.
172. Simon P.M., Goode P.L., Mobasseri A., Zopf D. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infection and immunity 1997, 65:750-757.
173. Simons K., van Meer G. Lipid sorting in epithelial cells. Biochemistry 1988, 27:6197-6202.
174. Singh J., Rivenson A., Tomita M., et al. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 1997, 18:833-841.
175. Smithers G.W. Whey and whey proteins - From "gutter-to-gold". International Dairy Journal 2008, 18:695-704.
176. Sorensen L.K. A liquid chromatography/tandem mass spectrometric approach for the determination of gangliosides GD3 and GM3 in bovine milk and infant formulae. Rapid Communications in Mass Spectrometry 2006, 20:3625-3633.
177. Stins M., Prasadarao N., Ibric L., Kim K. Binding characteristics of S fimbriated Escherichia coli to isolated brain microvascular endothelial cells. American Journal of Pathology 1994, 145:1228-1236.
178. Strömqvist M., Falk P., Hansson S.B.L., et al. Human milk k-casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa. Journal of Pediatric Gastroenterology and Nutrition 1995, 21:288-296.
179. Strum J.S., Kim J., Wu S., et al. Identification and accurate quantitation of biological oligosaccharide mixtures. Analytical Chemistry 2012, 84:7793-7801.
180. Sudo N., Sawarnura S., Tanaka K., et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. Journal of Immunology 1997, 159:1739-1745.
181. Sullivan S., Schanler R.J., Kim J.H., et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. Journal of Pediatrics 2010, 156:562-567.
182. Sundekilde U.K., Barile D., Meyrand M., et al. Natural variability in bovine milk oligosaccharides from Danish Jersey and Holstein-Friesian breeds. Journal of Agricultural and Food Chemistry 2012, 60:6188-6196.
183. Svennerholm L., Fredman P. A procedure for the quantitative isolation of brain gangliosides. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1980, 617:97-109.
184. Tao N., DePeters E.J., Freeman S., et al. Bovine milk glycome. Journal of Dairy Science 2008, 91:3768-3778.
185. Tao N., DePeters E.J., German J.B., Grimm R., Lebrilla C.B. Variations in bovine milk oligosaccharides during early and middle lactation stages analyzed by high-performance liquid chromatography-chip/mass spectrometry. Journal of Dairy Science 2009, 92:2991-3001.
186. Tao N., Ochonicky K.L., German J.B., Donovan S.M., Lebrilla C.B. Structural determination and daily variations of porcine milk oligosaccharides. Journal of Agricultural and Food Chemistry 2010, 58:4653-4659.
187. Tao N., Wu S., Kim J., et al. Evolutionary glycomics: Characterization of milk oligosaccharides in primates. Journal of Proteome Research 2011, 10:1548-1557.
188. Thibault H., Aubert-Jacquin C., Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. Journal of Pediatric Gastroenterology and Nutrition 2004, 39:147-152.
189. Tolborg J.F., Petersen L., Jensen K.J., et al. Solid-phase oligosaccharide and glycopeptide synthesis using glycosynthases. Journal of Organic Chemistry 2002, 67:4143-4149.
190. Turnbaugh P.J., Hamady M., Yatsunenko T., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
191. Urashima T., Taufik E. Oligosaccharides in milk: Their benefits and future utilization. Media Peternakan 2010, 33(3):189-197.
192. United States Dairy Export Council Global Dairy Market Outlook 2013, 17(7):1-7. U.S. Export 5 Year Trend.
193. Valenti P., Antonini G. Lactoferrin: An important host defence against microbial and viral attack. Cellular and Molecular Life Sciences 2005, 62:2576-2587.
194. Vazquez E., Gil A., Rueda R. Dietary gangliosides positively modulate the percentages of Th1 and Th2 lymphocyte subsets in small intestine of mice at weaning. Biofactors 2001, 15:1-9.
195. Walzem R.L., Dillard C.J., German J.B. Whey components: Millennia of evolution create functionalities for mammalian nutrition: What we know and what we may be overlooking. Critical Reviews in Food Science and Nutrition 2002, 42:353-375.
196. Ward P.P., Uribe-Luna S., Conneely O.M. Lactoferrin and host defense. Biochemistry and Cell Biology 2002, 80:95-102.
197. Ward R.E., Ninonuevo M., Mills D.A., Lebrilla C.B., German J.B. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Applied and Environmental Microbiology 2006, 72:4497-4499.
198. Ward R.E., Watzke H.J., Jimenez-Flores R., German J.B. Bioguided processing - A paradigm change in food production. Food Technology 2004, 58:44-48.
199. Wickramasinghe S., Hua S., Rincon G., et al. Transcriptome profiling of bovine milk oligosaccharide metabolism genes using RNA-sequencing. PLoS One 2011, 6:e18895.
200. Wijngaard H., Hossain M.B., Rai D.K., Brunton N. Techniques to extract bioactive compounds from food by-products of plant origin. Food Research International 2012, 46:505-513.
201. Wu S., Grimm R., German J.B., Lebrilla C.B. Annotation and structural analysis of sialylated human milk oligosaccharides. Journal of Proteome Research 2010, 10:856-868.
202. Wu S., Salcedo J., Tang N., et al. Employment of tandem mass spectrometry for the accurate and specific identification of oligosaccharide structures. Analytical Chemistry 2012, 84:7456-7462.
203. Wu S., Tao N., German J.B., Grimm R., Lebrilla C.B. Development of an annotated library of neutral human milk oligosaccharides. Journal of Proteome Research 2010, 9:4138-4151.
204. Yamakawa T., Nagai Y. Glycolipids at cell-surface and their biological functions. Trends in Biochemical Science 1978, 3:128-131.
205. Yatsunenko T., Rey F.E., Manary M.J., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
206. Yekta M.A., Verdonck F., Van Den Broeck W., et al. Lactoferrin inhibits E. coli O157: H7 growth and attachment to intestinal epithelial cells. Veterinarni Medicina 2010, 55:359-368.
207. Zhang J., Ren Y., Huang B., et al. Determination of disialoganglioside GD3 and monosialoganglioside GM3 in infant formulas and whey protein concentrates by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Journal of Separation Science 2012, 35:937-946.
208. Zivkovic A.M., German J.B., Lebrilla C.B., Mills D.A. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proceedings of the National Academy of Sciences 2011, 108:4653-4658.
209. Zydney A.L. Protein separations using membrane filtration: New opportunities for whey fractionation. International Dairy Journal 1998, 8:243-250.
210. Food and Agriculture Organization of the United Nations. http://www.fao.org/.
211. Glycoforum. http://www.glycoforum.gr.jp/.
212. Scripps Center for Metabolomics and Mass Spectrometry. http://masspec.scripps.edu/.
213. UC Davis, Department of Food Science and Technology. http://foodbioactives.ucdavis.edu/.
214. UC Davis, Food Science and Technology. http://foodscience.ucdavis.edu/processing-facilities/milk-processing-laboratory.